-
1.Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 有权
标题翻译: 取代的乙炔衍生物及其作为mGluR4的正变构调节剂的用途公开(公告)号:US20150376182A1
公开(公告)日:2015-12-31
申请号:US14766570
申请日:2014-01-15
申请人: MERCK PATENT GMBH
IPC分类号: C07D471/04 , A61K31/437 , C07D215/12 , C07D215/06 , A61K31/47
CPC分类号: C07D471/04 , A61K31/437 , A61K31/47 , A61K45/06 , C07D215/06 , C07D215/12 , C07D409/06
摘要: The present invention relates to novel acetylene derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.
摘要翻译: 本发明涉及新的乙炔衍生物作为调节代谢型谷氨酸受体亚型4(mGluR4)的正变构调节剂和/或改变谷氨酸水平或谷氨酸能信号。
-
公开(公告)号:US20160340323A1
公开(公告)日:2016-11-24
申请号:US15227638
申请日:2016-08-03
申请人: Merck Patent GmbH
发明人: Bayard R. HUCK , Ruoxi LAN , Justin POTNICK , Lizbeth Celeste DESELM , Mark W. CRONIN, JR. , Constantin NEAGU , Xiaoling CHEN , Roch BOIVIN , Theresa L. JOHNSON , Andreas GOUTOPOULOS
IPC分类号: C07D253/08 , C07D403/12 , C07D401/12
CPC分类号: C07D253/08 , A61K31/519 , A61K31/53 , A61K45/06 , C07D401/12 , C07D403/12 , C07D471/04
摘要: Novel azaquinazoline carboxamide derivatives of formula (I) wherein W1, W2, W3, W4, R1, R2, R3 and m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.
摘要翻译: 其中上述定义的W1,W2,W3,W4,R1,R2,R3和m是p70S6K抑制剂,并且可以用于治疗过度增殖性疾病。
-
3.
公开(公告)号:US20160339028A1
公开(公告)日:2016-11-24
申请号:US15227017
申请日:2016-08-03
申请人: Merck Patent GmbH
发明人: Bayard R. HUCK , Xiaoling CHEN , Yufang XIAO , Ruoxi LAN , Lizbeth Celeste DE SELM , Constantin NEAGU , Justin POTNICK , Srinivasa R. KARRA , Theresa L. JOHNSON
IPC分类号: A61K31/517 , C07D401/12 , C07D239/74 , C07D403/04 , A61K31/496 , C07D215/48 , A61K31/47 , C07D401/14 , A61K31/4709 , C07D403/12 , C07D401/04
CPC分类号: A61K31/517 , A61K31/47 , A61K31/4709 , A61K31/496 , C07D215/48 , C07D239/74 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12
摘要: The invention provides novel heterocyclic carboxamide compounds compounds according to Formula (I) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
摘要翻译: 本发明提供了根据式(I)的新型杂环羧酰胺化合物其用于治疗过度增殖性疾病如癌症的制造和用途。
-
公开(公告)号:US20220389004A1
公开(公告)日:2022-12-08
申请号:US17271009
申请日:2019-08-26
申请人: Merck Patent GmbH
发明人: Richard D. CALDWELL , Lesley LIU-BUJALSKI , Justin POTNICK , Constantin NEAGU , Shashank KULKARNI , Reinaldo JONES , Hui QIU
IPC分类号: C07D471/04
摘要: The present invention relates to fused imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
-
5.
公开(公告)号:US20160058763A1
公开(公告)日:2016-03-03
申请号:US14847561
申请日:2015-09-08
申请人: Merck Patent GmbH
发明人: Bayard R. HUCK , Xiaoling CHEN , Yufang XIAO , Ruoxi LAN , Lizbeth Celeste DE SELM , Constantin NEAGU , Justin POTNICK , Srinivasa R. KARRA , Theresa L. JOHNSON
IPC分类号: A61K31/517 , A61K31/4709 , A61K31/496 , A61K31/47
CPC分类号: A61K31/517 , A61K31/47 , A61K31/4709 , A61K31/496 , C07D215/48 , C07D239/74 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12
摘要: The invention provides novel heterocyclic carboxamide compounds according to Formula (I) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
摘要翻译: 本发明提供了根据式(I)的新型杂环羧酰胺化合物,其用于治疗过度增殖性疾病如癌症的制备和用途。
-
公开(公告)号:US20150361046A1
公开(公告)日:2015-12-17
申请号:US14765048
申请日:2014-01-22
申请人: MERCK PATENT GMBH
发明人: Justin POTNICK
IPC分类号: C07D217/26 , C07D213/85 , A61K31/438 , A61K31/472 , C07D495/04 , C07D491/052 , A61K31/5377
CPC分类号: C07D217/26 , A61K31/438 , A61K31/472 , A61K31/5377 , C07D213/85 , C07D491/052 , C07D495/04
摘要: The present invention relates to novel substituted pyridine derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 3 (mGluR3) and/or altering glutamate level or glutamatergic signalling.
摘要翻译: 本发明涉及新的取代吡啶衍生物作为调节代谢型谷氨酸受体亚型3(mGluR3)的正变构调节剂和/或改变谷氨酸水平或谷氨酸能信号。
-
公开(公告)号:US20180237402A1
公开(公告)日:2018-08-23
申请号:US15960759
申请日:2018-04-24
申请人: Merck Patent GmbH
发明人: Bayard R. HUCK , Ruoxi LAN , Justin POTNICK , Lizbeth Celeste DESELM , Mark W. CRONIN, JR. , Constantin NEAGU , Xiaoling CHEN , Roch BOIVIN , Theresa L. JOHNSON , Andreas GOUTOPOULOS
IPC分类号: C07D253/08 , C07D403/12 , C07D401/12 , A61K31/53 , A61K31/519 , C07D471/04 , A61K45/06
CPC分类号: C07D253/08 , A61K31/519 , A61K31/53 , A61K45/06 , C07D401/12 , C07D403/12 , C07D471/04
摘要: Novel azaquinazoline carboxamide derivatives of formula (I) wherein W1, W2, W3, W4, R1, R2, R3 and m which are defined above, are p70S6K inhibitor, and can be employed, inter alia, for the treatment of hyperproliferative disorders.
-
公开(公告)号:US20160096834A1
公开(公告)日:2016-04-07
申请号:US14876224
申请日:2015-10-06
申请人: Merck Patent GmbH
发明人: Pascale GAILLARD , Jeyaprakashnarayanan SEENISAMY , Lesley LIU-BUJALSKI , Richard D. CALDWELL , Justin POTNICK , Hui QIU , Constantin NEAGU , Reinaldo JONES , Annie Cho WON , Andreas GOUTOPOULOS , Brian A. SHERER , Theresa L. JOHNSON , Anna GARDBERG
IPC分类号: C07D471/04 , C07D519/00
CPC分类号: C07D471/04 , C07D519/00
摘要: The present invention relates to imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof, useful as BTK inhibitors.
摘要翻译: 本发明涉及可用作BTK抑制剂的咪唑并吡啶化合物及其药学上可接受的组合物。
-
9.Spiro-Quinazolinone Derivatives and their Use as Positive Allosteric Modulators of mGluR4 有权
标题翻译: 螺 - 喹唑啉酮衍生物及其作为mGluR4的正变构调节剂的用途公开(公告)号:US20150361079A1
公开(公告)日:2015-12-17
申请号:US14765615
申请日:2014-01-23
申请人: MERCK PATENT GMBH
发明人: Nadia BRUGGER , Brian L. HODOUS , Amanda E. SUTTON , Justin POTNICK , Theresa L. JOHNSON , Thomas E. RICHARDSON , Thomas Francis Nelson HAXELL , James M. DORSEY , Robert James FOGLESONG
IPC分类号: C07D471/10 , C07D487/10 , A61K31/4747 , C07D498/10 , A61K31/537 , A61K31/527 , C07D239/91
CPC分类号: C07D471/10 , A61K31/4747 , A61K31/527 , A61K31/537 , C07D239/91 , C07D487/10 , C07D498/10
摘要: The present invention relates to novel spiro-quinazolinone derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling.
摘要翻译: 本发明涉及新的螺 - 喹唑啉酮衍生物作为调节代谢型谷氨酸受体亚型4(mGluR4)和/或改变谷氨酸水平或谷氨酸能信号传导的正变构调节剂。
-
-
-
-
-
-
-
-